Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120145) titled 'Effect of Early Oral Aspirin on Immune Reconstitution in HIV-1 Infected Patients: A Clinical Stud' on March 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Ditan Hospital, Capital Medical University
Condition:
HIV infection
Intervention:
Aspirin combined with ART Group:Oral aspirin (100 mg) administered daily in the morning, on the background of continuous antiretroviral therapy (ART), for a duration of 24 weeks.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Aspirin combined with ART Group:30;Standard ART ...